MedTrace Logo

Prevalence and Characteristics of Widespread Pain in People With Knee Osteoarthritis

NCT06854237 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 114

Last updated 2025-06-06

No results posted yet for this study

Summary

The goal is to evaluate whether the number of pain sites or pain estimation with Instant and Constant Osteoarthritis Pain (ICOAP) is related to functional impairment in the lower extremity in people with knee osteoarthritis (KOA).

The main questions it aims to answer are:

1. What is the relationship between the number of pain sites and physical function when adjusted for age, sex, education level, and origin in people with KOA?
2. What is the relationship between pain experience measured with ICOAP (constant and intermittent pain subscales, as well as total score) and reduced physical function when adjusted for age, sex, education level, and origin in people with KOA?
3. What is the relationship between demographic data (age, sex, BMI, origin, level of education) and reduced physical function in people with KOA?

Participants were recruited from five rehabilitation clinics in primary care within the Västra Götaland region, for another study (NCT03855813). Patients with diagnosed KOA were asked to participate in the study. The patients mostly had problems in the knee joint but could also have osteoarthritis (OA) in other joints.

Conditions

Sponsors & Collaborators

  • Vastra Gotaland Region

    lead OTHER_GOV

Principal Investigators

  • Chan-Mei Ho-Henriksson, MD · Västra Götalandsregionen, Närhälsan, Närhälsan Lidköping Rehabmottagning, Lidköping, Sweden

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-06
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06854237 on ClinicalTrials.gov